Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
about
Mirk kinase inhibition targets ovarian cancer ascites.Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy.Dysbindin promotes progression of pancreatic ductal adenocarcinoma via direct activation of PI3K.
P2860
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@ast
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@en
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@nl
type
label
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@ast
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@en
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@nl
prefLabel
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@ast
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@en
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@nl
P2093
P2860
P356
P1433
P1476
Mirk/dyrk1B kinase is upregulated following inhibition of mTOR.
@en
P2093
Daina Z Ewton
Eileen Friedman
Xiaobing Deng
P2860
P304
P356
10.1093/CARCIN/BGU058
P407
P577
2014-03-03T00:00:00Z